• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Complete Response Letter

Delayed on hold
Biotech

Vanda sues FDA over months-long hearing delay

Vanda says CDER “has asked the commissioner to allow it to take six months to merely respond to Vanda’s request for a hearing."
Gabrielle Masson Apr 23, 2025 10:33am
Graphic image of a red thumbs down against a blue background

Aldeyra’s dry eye drug suffers second FDA rejection

Apr 3, 2025 8:46am
Image of a neon sign with the word no lit up next to an unlit yes

FDA hits Zealand Pharma's Gattex challenger with CRL

Dec 19, 2024 4:22pm
Graphic image of a red thumbs down against a blue background

FDA rejects Applied filing for rare disease approval

Dec 2, 2024 5:27am
showdown clash versus vs crash lightning fight dispute

Vanda receives FDA rejection, issues fiery response

Sep 19, 2024 8:02am
Graphic image of a red thumbs down against a blue background

FDA rejects Regeneron bispecific, delaying rival to J&J, Pfizer

Aug 21, 2024 5:48am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings